Bexarotene effect on gemcitabine resistant non-small lung cancer cell line - - GEO DataSets - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

Result Filters

Summary

Format

Summary
Summary (text)
Unique Identifier List

Send to:

Choose Destination

File
Clipboard
Collections

Links from GEO Profiles

Full record GDS2777

Bexarotene effect on gemcitabine resistant non-small lung cancer cell line

Analysis of gemcitabine (Gem)-resistant non-small lung cancer Calu3 cells treated with bexarotene (Bex). Acquired drug resistance is a major obstacle in cancer therapy. Results provide insight into molecular mechanisms underlying the ability of bexarotene to overcome Gem-resistance in Calu3 cells.

Organism:: Homo sapiens

Type:: Expression profiling by array, count, 5 agent, 2 cell line sets

Platform:: GPL96
Series:: GSE6914
20 Samples

Download data: CEL, EXP

DataSet

Accession:: GDS2777

ID:: 2777

PubMed Similar studies GEO Profiles Analyze DataSet

Supplemental Content

Related information

PubMed
Related PubMed entries
Similar studies
Similar studies
GEO Profiles
Related GEO
BioProject
BioProject links
GEO DataSets
Related GEO DataSets
Taxonomy
Taxonomy

Important Links

Recent activity

Clear Turn Off Turn On

Related DataSets for GEO Profiles (Select 40507069) (1)
GEO DataSets
Bexarotene effect on gemcitabine resistant non-small lung cancer cell line
Bexarotene effect on gemcitabine resistant non-small lung cancer cell line
Accession: GDS2777

GEO DataSets

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

You are here: NCBI > Genes & Expression > Gene Expression Omnibus (GEO) Datasets